Thursday, July 4, 2013

ResearchMoz Provide - China Blood Product Industry Analysis Report, 2012-2015

Researchmoz presents this most up-to-date research on "ResearchMoz Provide - China Blood Product Industry Analysis Report, 2012-2015 ". The report focuses primarily on quantitative market metrics in order to characterize the growth and evolution.


 


Plasma is a key raw material of the blood product industry. In August 2011, China shut down 16 plasma stations in Guizhou, resulting in a decrease of 15% in the plasma volume of the year. However, due to the implementation of favorable policies, widening gap between supply and demand, rising product prices and other factors, more than 150 plasma stations in China produced about 3,600 tons of plasma in 2012, up 14.2% year on year. 

From 2012 to mid-2013, new plasma stations of some Chinese enterprises have started plasma collection or obtained plasma collection permits, such as Yuechi plasma station of Jiangxi Boya Bio-Pharmaceutical, Changyuan plasma station of Hualan Bio, and Caoxian plasma station of China Biologic Products. It’s expected that China’s plasma supply tension will be further eased after 2013. 
 
 


1. Profile of Blood Products
1.1 Definition
1.2 Classification
1.3 Recombinant Blood Products
1.4 Industry Chain
1.5 Features

2. Overview of China Blood Products Industry
2.1 Market Size
2.2 Development Status
2.3 Supply & Demand
2.3.1 Supply 
2.3.2 Demand 
2.4 Market Competition
2.5 Operating Environment
2.5.1 International Market
2.5.2 Policies
2.5.3 Domestic Biopharmaceutical Market
2.6 Import & Export



For More Information Kindly Contact:
Email: sales@researchmoz.us
WebSite: http://www.researchmoz.us/
Follow Us On:
http://www.linkedin.com/company/researchmoz
https://twitter.com/researchmoz
https://www.facebook.com/pages/ResearchMoz/267379433319
 
 
 
 

No comments:

Post a Comment